Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125266211 | 12526621 | 1 | I | 20150618 | 20150701 | 20160705 | 20160705 | PER | US-ENDO PHARMACEUTICALS INC.-2015-001746 | ENDO | 84.18 | YR | M | Y | 77.18000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125266211 | 12526621 | 1 | PS | NYSTATIN SUSPENSION | NYSTATIN | 1 | Oral | 5 ML FOUR TIMES DAILY SWISH AND SWALLOW FOR 10 DAYS. | 65148 | SUSPENSION | |||||||||
125266211 | 12526621 | 2 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125266211 | 12526621 | 1 | Oesophageal infection |
125266211 | 12526621 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125266211 | 12526621 | Increased upper airway secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125266211 | 12526621 | 1 | 20150618 | 20150628 | 0 |